BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
The Most Paramount Crossroads in Olympic History - 2How did this 20-light-year-wide 'Diamond Ring' form in space? Maybe a cosmic bubble burst
- 3Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- 4'Stranger Things' Season 5: What's going on with Will Byers? That shocking Volume 1 plot twist, explained.
- 5Defense Minister Katz moves to extend IDF service to 36 months
- Hilary Duff releases 'Mature,' her 1st song in 10 years
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- See the moon shine with Saturn in the southern sky after sunset Dec. 26
- Japan deploys the military to counter a surge in bear attacks
- Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- Instructions to Floss Appropriately and Forestall Gum Sickness
- Support Your Wellness: 20-Minute Home Exercises That Work
- Newly identified species of Tanzanian tree toad leapfrog the tadpole stage and give birth to toadlets
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
